EP300 and leukemia: Previous studies have shown that RUNX1 transcription factors associate with co-activators CBP and p300 [21], whereas leukemia-associated RUNX1-ETO proteins do not interact with CBP/p300 family proteins, but rather with co-repressive proteins including HDACs.